arrow
N

Natalie Brajanovski

Peter MacCallum Cancer Centre
H指数:10
被引数:1,173

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer

RNA聚合酶I转录抑制剂CX-5461通过增强同源重组熟练的高级浆液性卵巢癌中的DNA损伤反应来与拓扑异构酶1抑制协同作用

2020-11-1130
OAAI
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer

CX-5461激活DNA损伤反应并证明在高级别浆液性卵巢癌中的治疗效果

2020-05-2697
OAAI
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma
2019-08-2291
OAAI
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study
2019-08-01129
OAAI
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance

Palbociclib与BRAF和MEK抑制剂协同治疗幼稚黑色素瘤,但在BRAF抑制剂耐药性发展后没有

2018-01-0359
OAAI